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Abstract
The Arf1 exchange factor GBF1 (Golgi Brefeldin A resistance factor 1) and its effector COPI are required for delivery of ATGL
(adipose triglyceride lipase) to lipid droplets (LDs). Using yeast two hybrid, co-immunoprecipitation in mammalian cells and
direct protein binding approaches, we report here that GBF1 and ATGL interact directly and in cells, through multiple
contact sites on each protein. The C-terminal region of ATGL interacts with N-terminal domains of GBF1, including the
catalytic Sec7 domain, but not with full-length GBF1 or its entire N-terminus. The N-terminal lipase domain of ATGL (called
the patatin domain) interacts with two C-terminal domains of GBF1, HDS (Homology downstream of Sec7) 1 and HDS2.
These two domains of GBF1 localize to lipid droplets when expressed alone in cells, but not to the Golgi, unlike the full-
length GBF1 protein, which localizes to both. We suggest that interaction of GBF1 with ATGL may be involved in the
membrane trafficking pathway mediated by GBF1, Arf1 and COPI that contributes to the localization of ATGL to lipid
droplets.
Citation: Ellong EN, Soni KG, Bui Q-T, Sougrat R, Golinelli-Cohen M-P, et al. (2011) Interaction between the Triglyceride Lipase ATGL and the Arf1 Activator
GBF1. PLoS ONE 6(7): e21889. doi:10.1371/journal.pone.0021889
Editor: Eliane F. Meurs, Institut Pasteur, France
Received October 13, 2010; Accepted June 14, 2011; Published July 18, 2011
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This work was funded by a grant from the ANR (Chaire d’Excellence), the CNRS, the Fondation pour la Recherche Medicale (FRM), and the Intramural
Program of NICHD. ENE was supported by a fellowship from the Ministe `re de l’Enseignement Supe ´rieur et de la Recherche. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jackson@ijm.univ-paris-diderot.fr
. These authors contributed equally to this work.
¤a Current address: Laboratoire de Biologie Cellulaire, Institut Jean-Pierre Bourgin, Institut National de la Recherche Agronomique (INRA), Versailles, France
¤b Current address: Imaging and Characterization Lab, 4700 King Abdullah University of Science and Technology, Thuwal, Kingdom of Saudi Arabia
¤c Current address: Institut Jacques Monod, CNRS and Universite ´ Paris Diderot-Paris 7, Paris, France
Introduction
Trafficking in the early secretory pathway requires two vesicular
trafficking machineries, the Sec12-Sar1-COPII and GBF1-Arf1-
COPI systems [1,2]. GBF1 and its yeast homologues Gea1p and
Gea2p are guanine nucleotide exchange factors (GEFs) for the
small G protein Arf1 that specifically recruit the COPI coat to
membranes to form COPI-coated vesicles [3,4,5]. GBF1 is a
peripherally associated membrane protein that localizes to
endoplasmic reticulum export site (ERES) membranes, promoting
their maturation to the ER-Golgi intermediate compartment
through recruitment of COPI and lipid modifying enzymes [6].
GBF1 also localizes to Golgi membranes, where it promotes
formation of COPI vesicles that recycle material from the Golgi
back to the ER [7]. Sec12 is an integral endoplasmic reticulum
(ER) membrane protein that activates the Sar1 small G protein to
promote COPII binding to membranes [6]. COPII recruitment
aids in the formation of COPII-coated vesicles and creates
membrane domains, ERES, competent for export of proteins
from the ER, the first step in the secretory pathway [8]. GBF1 is a
large multidomain protein that has several interacting partners,
including the COPI coat complex and the membrane tether p115
that regulates membrane fusion [5,9]. These proteins act
downstream of Arf1 activation, suggesting that GBF1 acts as a
scaffold to coordinate downstream events prior to its activation of
Arf1. At the trans-Golgi Network and endosomes, two other Arf1
GEFs, Brefeldin A-Inhibited Guanine nucleotide exchange factor
1 (BIG1) and BIG2, function in recruitment of coats specific to
these compartments [3,4,10].
Cells store energy in the form of triacylglycerol and cholesterol
esters in structures known as lipid droplets (LDs) – also called lipid
bodies, oil bodies and adiposomes [11,12,13,14,15]. These stores
can be mobilized under conditions of nutrient deprivation through
the action of lipases, including adipose triglyceride lipase (ATGL)
and hormone sensitive lipase (HSL) [14,16,17]. ATGL, also
known as PNPLA2 (for patatin-like phospholipase domain con-
taining 2) is a member of a family of LD-associated lipases that
catalyze the first step of triacylglycerol degradation upon
stimulation of lipolysis [16,18,19]. The patatin domain, named
after the plant lipase patatin, is found in a family of lipases that also
includes cytosolic phospholipase A2 (cPLA2) [16,18,20]. The
crystal structure of the patatin domain has been solved, revealing
an active site unlike the typical alpha/beta hydrolase fold, and
resembling that of cPLA2 [21]. CGI-58 is a well-studied interact-
ing partner of ATGL, which binds directly to the patatin domain
and acts as a co-activator which stimulates ATGL lipase activity
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21889[16,22,23,24,25]. ATGL and CGI-58, although highly upregu-
lated in adipocytes, are present in non-adipocyte cells as well, and
hence may play general roles in cellular lipid metabolism
[17,20,26].
LDs have a central hydrophobic core in which triacylglycerol
and cholesterol esters are stored, which is surrounded by a
phospholipid monolayer. Lipid-droplet associated proteins coat
the external surface of the LD, and include PAT (Perilipin/
ADRP/TIP47) proteins and lipases such as ATGL and HSL
[13,15,25,27]. Recently, numerous studies have shown that LDs
are not simply inert storage depots, but are dynamic organelles
that interface with membrane trafficking pathways [11,28,29].
One of the first clues came from proteomics studies of purified LDs
that turned up proteins involved in membrane trafficking includ-
ing Rab and Arf family proteins and SNAREs [29,30,31,32,33].
Mulitple Rab proteins have been implicated in LD metabolism,
with Rab18 and Rab5 having demonstrated roles in lipid droplet
metabolism [34,35]. Rab18 is localized to both the ER and LDs,
and its trafficking to LDs is triggered by lipolytic stimulation,
indicating a potential role in the breakdown of LDs during lipolysis
[35]. The SNARE proteins SNAP23 and the Arf family member
ARFRP1 have been shown to have a functional connection to
LDs, and SNAP23 appears to play a direct role in LD fusion
[36,37].
We have shown recently that GBF1, Arf1 and COPI are
required for delivery of lipid droplet-associated proteins such as
the triglyceride lipase ATGL to LDs in mammalian cells [38], and
a role for these proteins in LD morphology was discovered in
genome-wide screens in Drosophila melanogaster [39,40]. We also
demonstrated a role for Sar1 and COPII in trafficking of ATGL to
LDs [38]. We found that ATGL is tightly associated with
membranes, and when its delivery to LDs is blocked, it
accumulates on ER membranes [38]. However, some groups
have reported localization of ATGL to the cytoplasm in addition
to LDs [41,42]. In cells depleted of GBF1, ATGL colocalizes with
COPII components, at a subset of ERES [38]. These results
support the conclusion that ATGL is tightly associated with the
ER membrane from the time of its synthesis, and requires sorting
by COPII and COPI for its trafficking to LDs. Although the
COPII system is involved in targeting of ATGL to LDs, depletion
of COPII components does not affect LD size, either in HeLa cells
or in Drosophila S2 cells [38,39,40]. In contrast, depletion of GBF1
in HeLa cells or in Drosophila results in larger lipid droplets. In
addition, a more severe ATGL delivery defect was seen when
components of the GBF1-Arf1-COPI system were inactivated,
compared to the COPII system. These results suggest a more
direct role for GBF1, Arf1 and/or COPI in LD metabolism.
Our current study began with a yeast two-hybrid screen using
the Sec7 domain of BIG2 as bait. We identified the C-terminal
region of ATGL as an interacting partner, and this prompted us to
investigate the potential connections between ATGL and the Arf1
GEFs. Surprisingly, we found little evidence of a physiological
connection between ATGL and BIG2 or BIG1, but did find a role
for GBF1, as described above. Here we show that several domains
of GBF1 interact with ATGL directly, and that GBF1 and ATGL
interact in mammalian cells.
Results
ATGL is an interacting partner of the Arf1 activator GBF1
We carried out a yeast two-hybrid screen with the Sec7 domain
of the Arf1 GEF BIG2 as bait, screening a human brain cDNA
library. After multiple rounds of selection, 132 positive clones
were obtained and inserts sequenced. One clone contained the
C-terminal portion (amino acids 367 to 504) of adipose triglyceride
lipase (ATGL). We tested this clone for interaction with other Sec7
domains. We included those of GBF1 and ARNO, which have
Arf1 as their preferred substrate, and EFA6, which is specific for
Arf6. (Our BIG1 Sec7 domain constructs were not functional in
yeast two-hybrid assays). The Arf1-specific GEFs GBF1 and
ARNO showed a robust interaction with the C-terminus of
ATGL, but no interaction was seen with the Sec7 domain of
EFA6, whose preferred substrate is Arf6 (Figure 1A).
We co-expressed full-length ATGL and the Sec7 domains of
GBF1, BIG1, BIG2 or EFA6 in Cos7 cells, and carried out co-
immunoprecipitation (co-IP) experiments. We found little if any
interaction with the wild type version of the GBF1 Sec7 domain,
but found that the catalytically inactive mutant version (in which a
key glutamic acid residue of the Sec7 domain is replaced with
lysine, abolishing exchange activity [43]) gave positive results
(Figure 1B). The expression of the wild type Sec7 domain likely
interferes with activity of the corresponding endogenous protein,
and is not well tolerated by cells. Using the EK mutant versions, all
of the Arf1-specific Sec7 domains interacted with ATGL in co-IP
experiments, but not the Sec7 domain of EFA6 (Figure 1C). Hence
by co-IP, like in the yeast two-hybrid assay, ATGL did not interact
with an Arf6-specific Sec7 domain, but among Arf1-specific Sec7
domains, interaction was promiscuous.
Our previous results have shown that GBF1 functions in
delivery of ATGL to LDs, suggesting that GBF1 might be the
physiological partner of ATGL [38]. The other large Arf1 GEFs,
BIG1 and BIG2, are highly homologous (74% identical in amino
acid sequence), and have many overlapping functions [7,44]. To
determine whether BIG1 and BIG2 might have functional
connections to ATGL, we first looked for interactions between
the regions of GBF1 and BIG1 flanking the Sec7 domain. We
expressed either the N- or C-terminal regions of GBF1 and BIG1
with ATGL in Cos7 cells, and tested interaction by co-IP. The N-
GBF1 and N-BIG1 constructs contain the entire region of GBF1
or BIG1, respectively, upstream of the Sec7 domain, and the C-
terminal GBF1 and BIG1 constructs contain the region spanning
domains HDS1, HDS2 and HDS3 downstream of the Sec7
domain (HDS1to3) (Figure 2). The expression levels of these
constructs in Cos7 cells are shown in Figure S1A, B. Interaction of
these domains was observed with GBF1, but not with the
equivalent domains of BIG1 (Figure S2A). Next, we tested
whether depletion of BIG1 and BIG2 played a role in delivery
of ATGL to LDs. Knocking down GBF1 in HeLa cells inhibited
localization of ATGL to LDs, as shown previously [38], but
knocking down BIG1 and BIG2 either individually (data not
shown) or both together (Figure S2B-D) had no effect. These
results strongly support the hypothesis that the functional
connection between GBF1 and ATGL is specific to GBF1 (at
least among the large Arf1 GEFs) and that regions outside the
Sec7 domain are important for specific interaction between GBF1
and ATGL.
Mapping Interaction Domains of ATGL and GBF1
We carried out yeast two-hybrid and co-IP experiments to map
the domains of interaction between GBF1 and ATGL. A diagram
of the domains we have used for each protein is shown in Figure 2.
For co-IP experiments, the levels of expression of each in Cos7
cells are shown in Figure S1. With the GBF1 Sec7 domain, in
addition to the interaction between the C-terminal region of
ATGL identified in the yeast two-hybrid screen, we found an
interaction with the hydrophobic domain just upstream (amino
acids 300–370) (Figure 3A). We also identified an interaction
between the Dimerization/Cyclophilin Binding (DCB) domain of
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as a weaker interaction with the C-terminal region downstream
(amino acids 366–504) (Figure 3B). A summary of the yeast two-
hybrid interaction data is shown in Table 1.
In co-IP experiments, we first tested the interaction between
endogenous GBF1 and ATGL proteins (Figure 4A). The
interaction was clear and reproducible, but appeared to be quite
weak, so we next tested interaction between tagged full-length
GBF1 and full-length ATGL expressed from plasmids. In this case
as well, we saw a weak interaction (Figure 4B; quantifications
shown in Figure 4C). For another interacting partner of GBF1, c-
COP, we also found a very weak interaction with the full-length
GBF1 protein [5]. In this case, interaction was stronger with
mutant and truncated versions of GBF1 that disrupt an
intramolecular interaction between the DCB and Homology
upstream of Sec7 (HUS) domains [5,45]. Introduction of a
mutation in the HUS domain of GBF1 that disrupts the DCB-
HUS interaction (D544A) led to a significant increase in the level
of interaction with ATGL (Figure 4B, C). Note that this mutation
does not change the level of expression of GBF1 (Figure S1A) nor
the amount of protein immunoprecipitated (Figure S3A). When
the entire DCB domain of GBF1 was deleted, interaction with
ATGL was stronger as well (Figure 4B). In both cases, the level of
interaction was about 10-fold higher than for wild type GBF1
(Figure 4C), with 2–4% of ATGL in cell lysates recovered in
association with these forms of GBF1. Similar results were
obtained for the N-terminal region of GBF1 alone: little
interaction with ATGL for the wild type form, and a 5–10-fold
higher level for the D544A mutant version (Figure 4B, C). We also
observed interaction of ATGL with the GBF1 DCB and HUS
domains alone (Figure S3B). These results indicate that the
N-terminus of GBF1 interacts with ATGL, and support the
conclusion that the intramolecular interaction between the DCB
and HUS domains inhibits this interaction.
The interaction of the N-terminally truncated form of GBF1
was stronger than with the mutant N-terminus alone, suggesting
further interaction sites in the C-terminus of the protein. Indeed,
we were able to detect interaction of the GBF1 HDS1 and HDS2
domains with ATGL (Figure 4D, E). These interactions were quite
strong in co-IPs, with approximately 10% of ATGL in the co-IPs
recovered in association with the HDS1 and/or HDS2 domains of
GBF1 (Figure 4D, E).
We next tested deleted forms of ATGL for interaction with
GBF1 in co-IP experiments. Deletion of the C-terminal region of
ATGL (366–504) did not affect the interactions with the N- and C-
terminal regions of GBF1 (Figure 4B–E, Figure S3B), consistent
with this region interacting primarily with the Sec7 domain
(Figure 1, 3B). Mutations in ATGL are linked to the human
disease NLSD with myopathy [46]. Three disease alleles lead to
truncation of the ATGL protein, including one truncation at
amino acid 289. Previous results have shown that these mutants
have higher lipase activity than the wild type protein in vitro [22].
ATGL(1–289) showed little if any interaction with the N-terminal
domains of GBF1 in co-IP experiments (Figure 4B). However,
ATGL(1–289) interacted well with the C-terminal HDS1 and
HDS2 domains of GBF1 (Figure 4D, E). Further truncation of
ATGL indicated that the minimal lipase domain (the patatin
domain) alone interacted with the GBF1 HDS1 and HDS2
domains. Hence the co-IP experiments confirm the yeast two-
hybrid results indicating that interactions with the N-terminus of
GBF1 occur primarily with the C-terminal regions of ATGL
(amino acids 300–504), and further show that the GBF1 HDS1
Figure 1. ATGL interacts with Arf1 GEF catalytic Sec7 domains. A- Yeast strain AH109 was transformed with the pACT2 library plasmid
containing amino acids 367–504 of ATGL fused to the activation domain of Gal4p, and pGBKT7 vectors carrying the indicated Sec7 domain fused to
the DNA-binding domain of Gal4p. Cells were spotted on the indicated selective plates and incubated for three days at 30uC. B-C- HA-tagged H.
sapiens ATGL was coexpressed in Cos7 cells either with Venus alone, or with the indicated Venus-tagged Sec7 domain; Sec7-EK indicates a mutation
of the catalytic glutamate residue to lysine. Immunoprecipitation was carried out with anti-GFP antibodies, and Cos7 cell lysates or eluted proteins
after immunoprecipitation were analyzed by Western blotting using anti-HA antibody (left panels). Lysates from cells expressing the indicated Venus-
GBF1 construct were analyzed by Western blotting using anti-GFP antibody (right panels). B- Wild type and E794K mutant Sec7 domains of GBF1. C-
EK mutant Sec7 domains of GBF1, BIG1, BIG2, ARNO and EFA6.
doi:10.1371/journal.pone.0021889.g001
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of ATGL (amino acids 1–178).
To determine whether catalytic activity of ATGL was important
for its interaction with the HDS1 and HDS2 domains of GBF1, we
expressed the S47A mutant, known to abolish lipase activity [20].
Immuno-EM analysis indicated that this catalytically inactive
mutant was expressed and localized properly to the surface of LDs
(Figure 5A). ATGL-S47A interacted with the GBF1 HDS1 and
HDS2 domains to an extent equivalent to the wild type ATGL
protein (Figure 5B), indicating that catalytic activity is not required
for interaction with GBF1. Interaction of the N-terminal domains
of GBF1 were also not affected by the S47A mutation in ATGL
(Figure S3C).
To determine whether the interactions between GBF1 and
ATGL domains were direct, we expressed individual domains of
both proteins in E. coli and tested binding. We found evidence for
three direct interactions. Approximately 1% of the DCB domain
of GBF1 in an E. coli extract interacted with the purified GST-
ATGL (300–504) C-terminal fragment (Figure 6A). This interac-
tion was specific, as no interaction was detected with the N-
terminal region of ATGL (1–366). These results are in good
agreement with the yeast two-hybrid results (Figure 3B). We also
observed a direct interaction between the N-terminus of ATGL
and the HDS1 domain of GBF1 (Figure 6B). Finally, we observed
a direct interaction between the C-terminus of ATGL and the
Sec7 domain of GBF1 (Figure 6C). We measured an apparent Kd
of 2.560.3 mM for this interaction (Figure 7). A summary of the
major interactions between the different domains of GBF1 and
ATGL are given in Table 2.
Localization of GBF1 HDS1 and HDS2 domains and ATGL
truncations to Lipid Droplets
As a first approach to understanding the physiological relevance
of the multiple interactions between domains of GBF1 and ATGL
that we demonstrated above, we sought to determine whether any
domains of GBF1 had a specific localization to LDs. Full-length
GBF1 localizes to both the Golgi complex and to LDs [38].
Preliminary localization studies in HeLa and Cos7 cells with
different domains of GBF1 showed that the N-terminus localized
predominantly to the cytosol, and that the entire C-terminal
region downstream of the Sec7 domain partially localized to LDs,
although there was also a large cytosolic pool (data not shown). To
determine whether the C-terminal HDS1 and HDS2 domains of
GBF1 are involved in localization to LDs, we expressed these
domains as fusions to GFP in HeLa cells. Each domain alone, and
a construct carrying both domains, localized to LDs (Figure 8).
Interestingly, and in contrast to wild type GBF1, these HDS1 and
HDS2 constructs did not localize to the Golgi (Figure 8).
We expressed different truncations of ATGL, with GFP fused to
their C-termini, in HeLa cells to test their localization. Full-length
Figure 2. Fragments of Homo sapiens GBF1 and ATGL proteins used in this study. A- Schematic diagram of GBF1 showing domains, with
regions used in the interaction experiments shown below. Amino acid numbers for the beginning and end of each fragment are indicated. Numbers
in black are for GBF1, numbers in red refer to BIG1. B- Schematic diagram of ATGL, with regions used in interaction experiments shown below. The
constructs indicated in bold are those that were demonstrated to interact directly when expressed in E. coli and were also shown to interact by co-
immunoprecipitation and yeast two-hybrid methods (with the exception of the HDS1-ATGL patatin domain interaction which was not detected in
yeast two-hybrid); see Table 2 for details. Note that slight variations in the borders of GBF1 constructs were used for the yeast two-hybrid
experiments (see Table 1), but essentially the same domains were used for all interaction studies.
doi:10.1371/journal.pone.0021889.g002
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results in a decrease in size of LDs when overexpressed [20]
(Figure 9A). We found that truncation of ATGL after amino acid
366 did not affect its localization to LDs, and like the wild type
protein, lipid droplets were smaller upon overexpression of this C-
terminally truncated form (Figure 9B). The truncated version of
ATGL corresponding to that expressed in NLSD disease patients,
ATGL(1–289), had a very interesting behavior. Consistent with its
high level activity in vitro [22], this truncation expressed in HeLa
cells resulted in a significantly reduced size of LDs (Figure 9C, E).
However, ATGL(1–289) did not accumulate on these smaller LDs
(Figure 9C), in contrast to the longer version, ATGL(1–366)
(Figure 9B). Further truncation of ATGL, containing the patatin
domain, ATGL(1–178), did accumulate on LDs but did not lead to
a decrease in their diameter (Figure 9D). Hence the N-terminal
region of ATGL containing the patatin domain is sufficient for
localization to LDs, but the region downstream, between amino
acids 178 and 366, appears to be involved in regulating interaction
of ATGL with LDs.
Discussion
We report here an interaction between the triglyceride lipase
ATGL and the Arf1 GEF GBF1. We found an interaction
between the endogenous proteins in mammalian cells by co-
immunoprecipitation, and sought to map their interaction
Figure 3. Yeast two-hybrid interactions between ATGL regions and GBF1 Sec7 and DCB domains. Yeast strain AH109 was transformed
with the indicated GBF1 domains in pGADT7, along with the indicated regions of ATGL in pGBKT7 plasmids. 10-fold serial dilutions of each doubly
transformed strain were spotted onto the indicated plates and incubated for 2 days at 30uC. A- GBF1 Sec7 domain. B- GBF1 DCB domain.
doi:10.1371/journal.pone.0021889.g003
Table 1. Yeast two-hybrid interactions between regions of GBF1 and ATGL.
ATGL
GBF1
Full-length
(M1-L504)
Patatin
(M1-L178) M1-M366 M1-L252 M366-L504 L300-L504 L300-T370 pGBKT7
DCB (V2-E202) 0 0 0 0 +++ + 0
HUS* (P203–P363) 0 0 0 0 0 0 0 0
HUS-D544A* (P203–P363) 0 0 0 0 0 0 0 0
N (M1-N698) 0 0 0 0 0 0 0 0
N-D544A (M1-N698) 0 0 0 0 0 0 0 0
Sec7 (F710-V894) 0 0 0 0 +++ + ++ 0
C (N896-S1856) 0 0 0 0 0 0 0 0
pGADT7 0 0 0 0 0 0 0 0
The indicated GBF1 fragments (first column) are in vector pGADT7 (amino acids at the beginning and end of each fragment are given), and the indicated portions of
ATGL (first row) are in pGBKT7. Level of growth on –HIS-LEU-TRP and –ADE–HIS-LEU-TRP selective plates is indicated by plus signs (+); ‘‘0’’ indicates no growth on
selective plates. *Note that these constructs differ from the HUS-GBF1 domain shown in Figure 2 in that the region between the HUS and Sec7 domains is not present.
doi:10.1371/journal.pone.0021889.t001
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interaction, which appears to be quite complex. Although we
originally identified ATGL as a binding partner of the Sec7
domain of the BIG2 Arf1 GEF, we do not find evidence for a
function of BIG1 or BIG2 in delivery of ATGL to LDs. A similar
situation has been reported recently for the yeast homologues of
GBF1 and BIG1/2, Gea2p and Sec7p, respectively. An interac-
tion between the Pik1p phosphoinositide-4 kinase and the Sec7
domain of the Arf1 GEF Gea2p was identified in a yeast two-
hybrid screen [47]. Interactions between Pik1p and Arf1-specific
Sec7 domains (those of Gea2p and Sec7p) were promiscuous, and
the originally identified Sec7 domain protein (Gea2p) was
apparently not the physiologically relevant partner, but rather
Sec7p was the GEF functionally linked to Pik1p [47]. Previously,
we found an interaction between the Gea2p Arf1 GEF and Drs2p,
an amino-phospholipid translocase (flippase) at the yeast TGN
[48,49]. Hence an emerging theme is functional connections
between the large Arf1 GEFs and lipid modifying enzymes,
highlighting the importance of these Arf1 activators in directly
regulating lipid metabolism in cells.
The interaction of GBF1 with ATGL appears to have
similarities to GBF1 interaction with the COPI subunit c-COP
[5]. There is only a weak interaction with wild type GBF1, but if
the intramolecular interaction between the DCB and HUS
domains is compromised through mutation or deletion, a robust
interaction is revealed. Our data are consistent with GBF1 being
in an initially closed conformation that interacts poorly with
binding partners, and that then becomes ‘‘opened up’’ to expose
the DCB and HUS domains for optimal interaction. Our domain
mapping experiments, using yeast two-hybrid, co-IP and expres-
sion of domains in E. coli, indicate that there are multiple
interactions of ATGL with at least four domains of GBF1. The N-
Figure 4. Interactions between GBF1 and ATGL assayed by co-immunoprecipitation. A- Immmunoprecipitation (IP) of endogenous
proteins. In the left panel, ATGL antibody (GFP antibody for the negative control) was used for the IP, and the western blot was performed with GBF1
antibody. In the right panel, GBF1 antibody (GFP antibody for negative control) was used for the IP, and the western blot was performd with ATGL
antibody. B- HA-tagged H. sapiens ATGL (either full-length or C-terminally truncated, as indicated) was coexpressed in Cos7 cells either with Venus
alone, or with the indicated Venus-tagged GBF1 region. Immunoprecipitation was carried out with anti-GFP antibodies, and Cos7 cell lysates or
eluted proteins after immunoprecipitation were analyzed by Western blotting using anti-HA antibody. For Western blots of the GFP-
immunoprecipitated bait proteins, see Figure S3A. C- Quantification represents the level of ATGL in the indicated immunoprecipitate, after
subtracting the value for pVenus and normalizing to the fragment with the highest level of interaction, that of the DDCB construct. This value was set
to 100% for each ATGL construct; as shown in part B, these values were equivalent for full-length ATGL and ATGL(1–366). Mean and standard
deviation of 2–4 independent experiments are shown. D- Co-immunoprecipitations from Cos7 cells expressing the indicated portion of HA-tagged H.
sapiens ATGL and Venus-tagged GBF1 C-terminal regions were carried out as in part B. E- Quantifications were carried out as in part C, with values
normalized to ATGL levels in HDS1 immunoprecipitations. Mean and standard deviation of 2–4 independent experiments are shown. Quantifications
were carried out only for the three GBF1 fragments whose expression levels were approximately equivalent; HDS2 was expressed at a significantly
higher level (see Figure S1A).
doi:10.1371/journal.pone.0021889.g004
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terminal region of ATGL, the GBF1 HDS1 and HDS2 domains
interact with the N-terminal patatin domain of ATGL (Table 2).
The Sec7 domain of GBF1 interacts well with region 366–504 of
the C-terminus of ATGL, and the DCB domain interacts most
strongly with region 300–370, which corresponds to a hydropho-
bic domain that has been postulated to interact directly with
lipids and is required for localization of ATGL to LDs in cells
[22,50].
We found that the patatin domain of ATGL (amino acids 1–
178) is targeted to LDs, but does not affect their size, unlike full-
length ATGL or longer C-terminal truncations. This result
Figure 5. Catalytic activity of ATGL is not required for LD localization or interaction with GBF1. A- Immuno-EM of HeLa cells expressing
GFP-tagged H. sapiens ATGL-S47A were treated with 200 mM oleic acid for 15 hours and labeled with gold-conjugated antibodies against GFP. The
majority of gold particles (examples indicated by arrows) are found on the surface of LDs. LD, lipid droplet. B- Co-immunoprecipitations from Cos7
cells expressing HA-tagged H. sapiens ATGL-S47A or ATGL(1–366)-S47A and Venus-tagged GBF1 fragments were carried out as in Figures 1 and 4;
Western blot of immunoprecipitates probed with anti-HA antibodies (upper panel); Cos7 cell extracts blotted with anti-GFP antibodies (lower panel).
doi:10.1371/journal.pone.0021889.g005
Figure 6. Direct interactions between domains of GBF1 and ATGL. A- Purified GST, GST-tagged ATGL(1–366) or GST-tagged ATGL(300–504)
was bound to glutathione Sepharose beads, then incubated with E. coli lysates expressing the His-tagged DCB domain of GBF1. Eluted proteins were
analyzed by Western blotting using His antibody. B- and C- The indicated His-tagged GBF1 domain expressed in E. coli was bound to Ni Sepharose 6
Fast Flow, then purified GST or the indicated GST-tagged domain of ATGL were incubated with the protein-bound beads. Eluted proteins were
analyzed by Western blotting using GST antibody. B- The HDS1-His domain of GBF1 bound to Ni Sepharose beads. C- The His-tagged Sec7 domain of
GBF1 bound to Ni Sepharose beads.
doi:10.1371/journal.pone.0021889.g006
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cells. The C-terminal truncation of ATGL removing the region
downstream of amino acid 366 has a behavior similar to that of the
wild type protein, both localizing to LDs and leading to a decrease
in their size. Our data support the conclusion that in addition to
the patatin domain, region 178–289 of ATGL is required for
ATGL activity on LDs, whereas region 289–366 (which interacts
with the N-terminal regions of GBF1) is required for stable
localization of this catalytically active portion of ATGL to LDs.
These results are in excellent agreement with the work of
Zimmermann and colleagues, who demonstrated that a mutation
downstream of the patatin domain, P195L, completely abolished
ATGL activity in vitro but retained the capacity to bind to LDs.
Both the Zimmermann and Liu groups have shown that C-
terminal truncations of ATGL fail to localize with LDs, and that
the hydrophobic domain is required for LD localization [22,50].
In addition, the C-terminus of ATGL (notably the region from
amino acids 290–504) negatively regulates the lipase activity of
ATGL in vitro [22]. The ATGL co-activator CGI-58 stimulates the
activity of both the full-length and the C-terminally truncated
forms of ATGL, but can stimulate the full-length autoinhibited
form of ATGL to only a limited extent [22]. Hence other factors,
such as GBF1, might be required to relieve the autoinhibition
mediated by the C-terminal region of ATGL.
Figure 7. The GBF1 Sec7 domain directly interacts with the ATGL (300–504) domain in vitro. A- Coomassie stained gel showing purified
recombinant GST-tagged ATGL (300–504) (1 mg, lane 1) and His-Sec7-GBF1(710–894) (1 mg, lane 2). M, molecular weight markers. B- 0.1 nmole of His-
Sec7-GBF1(710–894) were immobilized on a Ni Sepharose 6 Fast Flow resin, then incubated with either GST or GST-tagged ATGL(300–504) (0.5 mM
each) for 2.5 hours at 4uC. After washes, proteins were eluted, separated by SDS-PAGE followed by immunoblotting with anti-GST antibody (upper
panel) or by staining with Coomassie Brilliant Blue (lower panel). GST-tagged ATGL(300-504) specifically bound to the His-Sec7-GBF1 fragment. C-
Quantitative analysis of the interaction between His-tagged GBF1 Sec7 domain and GST-tagged ATGL (300–504) was performed. Various
concentrations (1–20 mM) of GST-tagged ATGL (300–504) were added to immobilized His-Sec7-GBF1(710–894) domain (0.1 nmole). Each sample was
washed and subjected to SDS-PAGE followed by immunoblotting with anti-GST antibody (upper panel). The amount of bound versus free GST-
tagged ATGL (300–504) domain is plotted (lower panel). Scatchard analysis indicated an apparent Kd of 2.560.3 mM (inset).
doi:10.1371/journal.pone.0021889.g007
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LDs when expressed in HeLa cells, and strikingly, do not localize at
all to the Golgi. ATGL and other LD-associated proteins have a
similar localization: there is no visible accumulation of LD proteins
at the Golgi [38,51]. This result suggests that there is a sorting event
that takes place in a pre-Golgi compartment whereby GBF1 is
directed either towards LDs or to the Golgi. The regions flanking
theHDS domains inGBF1mayplay a role indirecting GBF1tothe
Golgi, with trafficking to LDs representing a type of default
pathway. We found previously that ATGL is very tightly associated
with membranes, and when its trafficking to LDs is blocked, it
accumulates in structures at the ER containing COPII, which
Table 2. Summary of major interactions between GBF1 and ATGL.
Interaction Methods used Comments
GBF1 Full-length
ATGL Full-length
Co-IP:
- Endogenous proteins
- Tagged proteins expressed from plasmids
Interaction between full-length proteins is stronger when GBF1 HUS-
DCB interaction is disrupted (by D544A mutation in HUS domain or
deletion of DCB domain).
GBF1 DCB domain
ATGL C-terminus (aa300–504)
- Yeast 2-hybrid
- Co-IP tagged fragments
- Purified proteins
The GBF1 DCB domain interacts best with the hydrophobic domain
(aa300–370) of the ATGL C-terminus.
GBF1 Sec7 domain
ATGL C-terminus (aa300–504)
- Yeast 2-hybrid
- Co-IP tagged fragments
- Purified proteins
Direct interaction with an apparent Kd of approximately 2.5 mM.
GBF1 HDS1 domain
ATGL patatin domain (N-term)
- Co-IP tagged fragments
- Purified proteins
In co-IP experiments, GBF1 HDS2 also interacts with ATGL patatin
domain.
doi:10.1371/journal.pone.0021889.t002
Figure 8. The GBF1 HDS1 and HDS2 domains localize to lipid droplets in cells. HeLa cells transfected with Venus-tagged HDS1 and/or
HDS2 domains of GBF1 as indicated were treated with 400 mM oleic acid for 3 hours, then immunostained with antibodies against TIP47 (middle
panels). Venus fluorescence is shown on the left; the merge image on the right. Bar: 10 mm. A- Cells expressing the region of GBF1 from the
beginning of HDS1 to the end of HDS2, N-terminally tagged with Venus. B- Cells expressing the Venus-tagged HDS1 domain. C- Cells expressing
Venus-HDS2. Bar, 10 mm.
doi:10.1371/journal.pone.0021889.g008
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ERGIC elements upon recruitment of GBF1 and its activation of
Arf1 [8]. ERGIC elements, containing the marker ERGIC-53,
detach from the ER and form a pre-Golgi compartment that has
been referred to as the biosynthetic recycling compartment (BRC)
[52]. Saraste and Goud have proposed that this compartment,
parallel to the endocytic recycling compartment (ERC), acts as a
sorting station for multiple pathways, including anterograde
transport of secretory proteins to the Golgi and retrograde recycling
back to the ER [52]. We showed previously that the GBF1-
dependent pathwaythat deliversATGLto LDsincludesERGIC-53
but not the Golgi protein GM130 [38], suggesting that it bifurcates
from the secretory pathway at the level of the ERGIC/BRC. Since
GBF1 functions in both trafficking to the Golgi and to LDs
[3,38,39], we propose that the GBF1-ATGL interaction might be
involved in a sorting step at the pre-Golgi BRC compartment that
directs ATGL and the GBF1-Arf1-COPI machinery to LDs.
Materials and Methods
Strains, plasmids and antibodies
Plasmids used in this study are listed in Table S1. Point
mutations were introduced using the QuickChange II XL site-
directed mutagenesis kit (Stratagene). All constructs were
Figure 9. The C-terminal region of ATGL regulates its localization to LDs in cells. HeLa cells transfected with the indicated ATGL constructs
tagged at their C-terminus with GFP were treated with 400 mM OA for 3 hours, then immunostained with antibodies against TIP47 (middle panel).
GFP fluorescence is shown on the left; the merge image on the right. Bar: 10 mm. A- Cells expressing full-length ATGL(1–504)-GFP. B- Cells expressing
ATGL(1–366)-GFP. C- Cells expressing ATGL(1–289)-GFP. D- Cells expressing ATGL(1–178)-GFP. E- LD diameters were measured in cells expressing
ATGL(1–289)-GFP and in control cells. Mean and standard deviation of three independent experiments are shown. Bar, 10 mm.
doi:10.1371/journal.pone.0021889.g009
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pGBKT7-ATGL(300–504), and pGBKT7-ATGL(366–504) were
constructed by insertion of the ORF fragment amplified by PCR
into EcoRI and SalI sites of pGBKT7 (Clontech). pGEX-4T1-
ATGL(1–366), pGEX-4T1-ATGL(300–504), and pGEX-4T1-
ATGL(1–178) were constructed by insertion of the ORF fragment
amplified by PCR into EcoRI and SalI sites of pGEX-4T1 (GE
Healthcare). pcDNA-ATGL, pcDNA-ATGL(1–366), pcDNA-
ATGL(1–289), and pcDNA-ATGL(1–178) were constructed by
insertion of the ORF/ORF fragment amplified by PCR into
BamHI and XhoI sites of pcDNA3-HA (Invitrogen). pEGFP-N1-
ATGL, pEGFP-N1-ATGL-S47A, pEGFP-N1-ATGL(1–178),
pEGFP-N1-ATGL(1–289), pEGFP-N1-ATGL(1–366), pEGFP-
N1-ATGL(1–366)-S47A were constructed by insertion of the
ORF/ORF fragment amplified by PCR into BamHI and KpnI
sites of pEGFP-N1 (Clontech). pcDNA-ATGL-S47A and pcDNA-
ATGL(1–366)-S47A were constructed by subcloning from the
corresponding pEGFP-N1 plasmid into SalI and BamHI sites of
pcDNA3-HA.
pVenus-C1 was constructed by removing the Venus coding
region from pVenus-N1 with AgeI and BspEI, and inserting this
fragment into pEYFP-C1 digested with the same enzymes. The
isoform of GBF1 used in this study has been described previously
[53]. pVenus-DDCB-GBF1 was constructed by digesting pVenus-
GBF1 with EcoRI, removing the fragment, and recircularizing the
gapped plasmid. Other pVenus plasmids expressing fragments of
GBF1, BIG1, BIG2, ARNO, or EFA6 were constructed by
insertion of the ORF fragments amplified by PCR into the XhoI
and KpnI sites of pVenus-C1. pBAD plasmids were constructed by
subcloning from pVenus plasmids into XhoI and KpnI sites of
pBAD/His C (Invitrogen). pET22b-HDS1-GBF1 was constructed
by insertion of the fragments amplified by PCR into the EcoRI
and SalI sites of pET22b (Novagen). The GST fusion proteins
and GBF1(908–1065)-His were produced using E. coli strain
BL21(DE3) (Novagen). Other His-tagged proteins were produced
using E. coli strain TOP10 (Novagen). pGBKT7-Sec7-BIG2 was
constructed by insertion into sites EcoRI and SalII, and pGBKT7-
Sec7-GBF1, pGBKT7-Sec7-EFA6 and pGBKT7-Sec7-ARNO
were constructed by insertion into EcoRI and BamHI sites of
pGBKT7 (Clontech). pGADT7-Sec7-GBF1 and pGADT7-DCB-
GBF1 were constructed by insertion into EcoRI/BamHI sites and
EcoRI/NcoI sites, respectively, of pGADT7 (Clontech). For the
plasmids listed in Table 1, the indicated regions of ATGL were
cloned into the EcoRI and SalI sites of pGBKT7; all GBF1
fragmentswereclonedintopGADT7usingthefollowingsites:DCB-
GBF1 (V2E202) EcoRI/NcoI, LinkerHUS-GBF1 (P203P363) SfiI/
XhoI, N-GBF1 (M1N698) NcoI/XhoI and C-GBF1 (N896S1856)
EcoRI/XhoI.
The following mouse monoclonal antibodies were used: clone
HA-7 ascites fluid (Sigma) against the HA tag, clone GST-2 ascites
fluid (Sigma) against GST, anti-GFP (Roche Diagnostics), QIAex-
press Anti-His antibodies (Qiagen)againsttheHis tagand guineapig
anti-TIP47 from Fitzgerald Industries International (Concord, MA,
USA). ATGL [20] and GBF1 [5] antibodies have been described.
Yeast two-hybrid assays
Yeast two-hybrid experiments were carried out as described
previously [5]. The yeast two-hybrid screen was carried out using a
human brain cDNA library (Clontech) with the pGBKT7-Sec7-
BIG2 as bait, in strain AH109. 3610
6 clones were screened, 1843
clones picked after plating the library on selective plate (medium
stringency), and after multiple tests of growth on -Ade-His-Trp-
Leu selective plates, 132 clones were extracted from yeast cells and
inserts sequenced.
Expression of recombinant proteins in Escherichia coli
GST-tagged proteins were expressed in BL21(DE3) E. coli
(Novagen) in 2xTY medium (GST-ATGL(300–504), GST-
ATGL(1–178)) or in LB medium (GST, GST-ATGL(1–366))
induced with IPTG at 37uC for 4 hr (GST) or 28uC for 4 hr
(GST-ATGL(1–366) and GST-ATGL(1–178)) or 2.5 hours (GST-
ATGL(300–504). Cells were sonicated in TEX buffer (20 mM
Tris-HCl pH 7.5, 30 mM KCl, 2 mM EDTA, 10% glycerol,
0.1 mM b-mercaptoethanol) in the presence of Complete Mini
Protease Inhibitor cocktail (Roche Diagnostics) then centrifuged at
4uC. Proteins were purified on glutathione Sepharose 4B resin (GE
Healthcare). Eluted proteins were dialyzed against 50 mM Tris-
HCl pH 7.5, 30 mM NaCl, 1 mM DTT buffer, concentrated with
Vivaspin system and loaded on a HiPrep 26/60 Sephacryl S-200
HR column. Eluted proteins were concentrated with Vivaspin
system and dialyzed against the same buffer containing 50%
glycerol. Proteins were kept at 220uC.
His-tagged proteins with the exception of GBF1(908–1065)-His
were expressed in TOP10 cells (Novagen) in 2xTY medium at
37uC, and induced with arabinose. GBF1(908–1065)-His expres-
sion was performed in BL21(DE3) cells cultured in 2xTY medium
at 37uC, and induced with IPTG. Cells were lysed in TEX buffer
in the presence of lysozyme, DNaseA and Complete Mini Protease
Inhibitor cocktail (Roche Diagnostics) or protease inhibitor mix
(GE Healthcare) then centrifuged at 4uC.
Pulldown assays
For the experiments involving HDS1-GBF1(908–1065)-His and
His-Sec7-GBF1(710–894), E. coli extracts were incubated with Ni
Sepharose 6 Fast Flow (GE Healthcare) at 4uC for 1 hr, with
rotation. Beads were washed with washing buffer W250 (20 mM
Tris-HCl pH 7.5, 250 mM NaCl), then were incubated with
purified GST fusion proteins with rotation at 4uC for 1 hr. Beads
were washed three times with W250. Bound proteins were eluted
by incubation with 50 mL of SDS-PAGE sample buffer and
heating at 95uC for 5 min, then were resolved by SDS-PAGE and
revealed by immunoblotting using antibodies to GST-protein
followed by chemiluminescent detection (GE Healthcare).
For the experiments involving His-DCB-GBF1(1–210), purified
GST-tagged proteins were incubated with Glutathione Sepharose
4B beads (GE Healthcare). Beads were washed two times with
washing buffer W250+ (20 mM Tris-HCl pH 7.5, 250 mM NaCl,
1 mM EDTA). Then, cellular extracts expressing His-tagged
proteins were incubated at 4uC for 1 hr. Beads were washed four
times with W250+ then one time with PBS. Bound proteins were
eluted as described above, then were resolved by SDS-PAGE and
revealed by immunoblotting using His-tag antibodies followed by
chemiluminescent detection (GE Healthcare).
Co-immunoprecipitation assays
Typically, Cos7 cells (ATCC) cultured in 3.5 cm culture dishes
were cotransfected using Lipofectamine (Invitrogen, Carlsbad,
CA, USA) with a pcDNA plasmid expressing a sub-region of HA-
tagged ATGL and either a pVenus or a pEYFP plasmid
expressing H. sapiens GBF1, BIG1, BIG2, ARNO or EFA6 (either
full-length or a sub-region) fused to Venus or YFP. After 20 hours
of expression, cells were washed two times with 5 mL of cold PBS,
then disrupted in 0.1 mL of cold Lysis buffer (50 mM Tris-HCl
pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.5% NP40). After
centrifugation at 4uC, cellular extracts were incubated with
0.8 mg of anti-GFP for 1.5 hours at 4uC with rotation. The resin
was washed three times with 1 mL of W100 buffer (20 mM Tris-
HCl pH 7.5, 100 mM NaCl, 1 mM EDTA) followed by one wash
with 1 mL of PBS. For co-immmunoprecipitation of endogenous
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Lysis buffer with antiproteases, the IP carried out as above but
using GBF1 (BD Biosciences) and ATGL (Cell Signaling)
antibodies, then the resin washed three times with W100 buffer.
Proteins were then eluted by incubation with 50 mL of SDS-PAGE
sample buffer for 5 minutes at 95uC. Eluted proteins were
separated by SDS-PAGE and analyzed by Western immunoblot-
ting using anti-HA or anti-GFP, and visualized using ECL
Advance (or ECL) Western Blotting Detection Kit (GE Health-
care). Membranes were imaged using a Luminescent Image
Analyzer LAS-3000 (FujiFilm), and the levels of GBF1 and ATGL
full-length proteins (both endogenous and ectopically expressed)
and fragments were quantified using ImageJ software.
Immunofluorescence and Microscopy
Oleic acid (OA) complexed to bovine serum albumin (BSA) was
prepared as described [38]. HeLa cells were grown in Dulbecco’s
Modified Eagle’s medium (DMEM) supplemented with 4.5 g/l
glucose and sodium pyruvate, 20 mM glutamine, 100 units/ml
penicillin G and 100 mg/ml streptomycin. HeLa cells (ATCC) were
transfected with plasmids on 24-well plates using Lipofectamine
(Invitrogen) according to the manufacturers’ instructions. At 8–
12 hours post transfection, cells were treated with 400 mMO Aa n d
incubated for 3 hours, then prepared for imaging.For overnight OA
treatment, at 8 hours post transfection, cells were treated with
200 mM OA and incubated for an additional 15 hours before
preparation for imaging. For immunofluorescence microscopy,
HeLa cells were grown on glass coverslips and fixed with 4%
formaldehyde. The cells were permeabilized with 0.1% saponin for
10 min, washed with PBS, then treated with 0.2% fatty-acid-free
BSAand0.2%gelatininPBSfor15 min,followedbya30 minwash
in PBS. Cells were probed with primary and secondary antibodies
for1 hourfollowed by30 minwashesinPBS.Tostainthe LDcores,
10 mg/ml of BODIPY 493/503 (Invitrogen) was incorporated with
the secondary antibodies. Coverslips were mounted on glass slides
using Fluoromount G (Southern Biotechnology Associates). Images
were acquired using an inverted confocal laser scanning microscope
(LSM510; Carl Zeiss). LDsizequantifications wereperformed using
the 510 Image Analyzer software. siRNAs and treatments were as
described previously [5,38].
HeLa cells were prepared for immuno-EM as described
previously [54]. Briefly, cells were fixed in 4% paraformaldehyde,
then blocked with 1% bovine serum albumin in PBS. Cells were
permeabilized and incubated with primary GFP antibody (rabbit
anti-GFP; Invitrogen) and subsequently incubated with nanogold-
conjugated secondary antibodies (Nanoprobes). Cells were fixed
with glutaraldehyde, treated with gold enhancement mixture for
6 min and postfixed in reduced osmium prior to embedding in
Epon. 70–100 nm sections were cut and stained with lead citrate
prior to imaging.
Supporting Information
Figure S1 Expression level of Venus-GBF1 and HA-
ATGL constructs in Cos7 cells. A- Lysates from Cos7 cells
transfected with the indicated Venus-tagged GBF1 regions were
analyzed by Western blotting using anti-GFP antibody. These
results are representative of experiments carried out at least 3
times; co-expression of ATGL constructs did not affect GBF1
levels. The DCB-linker constuct contains the DCB domain plus
the region between DCB and HUS domains (see Figure 2). B-
Western blot using GFP antibodies of lysates from Cos7 cells
transfected with the indicated Venus-tagged GBF1 or BIG1
construct. C- Western blot using HA antibodies of lysates from
Cos7 cells transfected with the indicated HA-tagged ATGL
construct.
(TIF)
Figure S2 Specificity of interaction between ATGL and
GBF1. A- HA-tagged H. sapiens ATGL was coexpressed in Cos7
cells with the indicated Venus-tagged GBF1 or BIG1 region.
Immunoprecipitation was carried out with anti-GFP antibodies,
and eluted proteins after immunoprecipitation were analyzed by
Western blotting using anti-HA antibody. B- to H- Depletion of
BIG1 and BIG2 does not affect ATGL association with LDs.
HeLa cells were transfected with siRNAs targeting BIG1 and
BIG2 together (B-, E-, F-), GBF1 (C-, G-) or lamin (negative
control) (D-, H-), then immunostained with antibodies against
TIP47 (B-, C-, D-, upper panels) or ATGL (B-, C-, D-, lower
panels), BIG2 (E-, upper panel), BIG1 (F-, G-, H-, upper panels) or
GBF1 (E-, F-, G-, H-, lower panels). Bar, 10 mm.
(TIF)
Figure S3 Coimmunoprecipitation of GBF1 and ATGL.
A- The indicated Venus-tagged GBF1 protein or region, or Venus
alone, was coexpressed in Cos7 cells with HA-tagged H. sapiens
ATGL. Immunoprecipitation was carried out with anti-GFP
antibodies, and eluted proteins after immunoprecipitation were
analyzed by Western blotting using anti-GFP antibody. B- ATGL
interacts with GBF1 DCB and HUS domains. HA-tagged H.
sapiens ATGL (full length or a deleted form) was coexpressed in
Cos7 cells with the indicated Venus-tagged GBF1 domain.
Immunoprecipitation was carried out with anti-GFP antibodies,
and eluted proteins after immunoprecipitation were analyzed by
Western blotting using anti-HA antibody. C- GBF1 – ATGL
interactions are not affected by the S47A mutation in ATGL. HA-
tagged H. sapiens ATGL-S47A was coexpressed in Cos7 cells with
the indicated Venus-tagged GBF1 region, and co-immunoprecip-
itation experiments carried out as in part B. The DCB-linker
constuct contains the DCB domain plus the region between DCB
and HUS domains (see Figure 2).
(TIF)
Table S1 Plasmids used in this study.
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